Revealed: Half-year results from Kilkenny-based Glanbia Plc 'ahead of expectations'
Resilient performance with adjusted EPS ahead of expectations
Highlights of the report include:
- First half momentum with volume growth across Health & Nutrition and Dairy Nutrition and sequential improvement in Performance Nutrition, resulting in an upgrade to full year adjusted EPS guidance;
- Glanbia announces that Paul Duffy will be appointed Company Chair on 1 January 2026 in place of Donard Gaynor who will retire on 31 December 2025
Hugh McGuire, Chief Executive Officer, said the "results reflect a first half of significant execution and progress as we generated 6% revenue growth in the period, underpinned by strong growth in H&N and DN and a sequential improvement in PN through the period as the Group navigated significant macroeconomic volatility.
"First half results were driven by volume growth, earnings and margin progression in H&N and DN, reflecting strong customer demand. This was offset by anticipated reduced performance in PN primarily as a result of elevated whey costs during the period. In the second quarter, we were pleased to see volume and price growth in our flagship brand, Optimum Nutrition. Within our H&N division, we have today announced the acquisition of Sweetmix, a Brazil-based nutritional premix and ingredients solutions business, facilitating continued growth in the Latin America region.
"We delivered strong operating returns and cash conversion and continue to have a disciplined approach to capital allocation, with a 10% increase in the interim dividend and €62.8 million returned to shareholders via share buyback programmes during the period.
"We are today upgrading our full year adjusted EPS guidance to 130 to 133 $cent as a result of increased revenue momentum in PN and improved margins in H&N. The category trends remain positive, and we expect to see continued improvement in volumes across PN in the second half of the year with continued momentum in H&N and DN.”